Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis

被引：0

作者：

Siegfried, Elaine C. ^{[1
,2
]}

Cork, Michael J. ^{[3
]}

Arkwright, Peter D. ^{[4
]}

Wollenberg, Andreas ^{[5
,6
]}

Eichenfield, Lawrence F. ^{[7
,8
]}

Ramien, Michele ^{[9
,10
]}

Khokhar, Faisal A. ^{[11
]}

Chen, Zhen ^{[11
]}

Zhang, Annie ^{[12
]}

Cyr, Sonya L. ^{[11
]}

机构：

[1] St Louis Univ, St Louis, MO USA

[2] Cardinal Glennon Childrens Hosp, St Louis, MO USA

[3] Univ Sheffield, Sheffield Dermatol Res, Sheffield, England

[4] Univ Manchester, Manchester, England

[5] Ludwig Maximilians Univ Munchen, Munich, Germany

[6] UZ Brussel, VUB, Brussels, Belgium

[7] Univ Calif San Diego, San Diego, CA USA

[8] Rady Childrens Hosp, San Diego, CA USA

[9] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada

[10] Univ Calgary, Calgary, AB, Canada

[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[12] Sanofi, Cambridge, MA USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷

关键词：

atopic dermatitis; children; infections; safety; dupilumab;

D O I：

10.1093/bjd/ljac140.031

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

337

引用

页数：2

共 50 条

[21] Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients [J].

Dal Bello, Giacomo ;

Maurelli, Martina ;

Schena, Donatella ;

Girolomoni, Giampiero ;

Gisondi, Paolo .

DERMATOLOGIC THERAPY, 2020, 33 (06)

[22] Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis [J].

Hamilton, Jennifer D. ;

Suarez-Farinas, Mayte ;

Dhingra, Nikhil ;

Cardinale, Irma ;

Li, Xuan ;

Kostic, Ana ;

Ming, Jeffrey E. ;

Radin, Allen R. ;

Krueger, James G. ;

Graham, Neil ;

Yancopoulos, George D. ;

Pirozzi, Gianluca ;

Guttman-Yassky, Emma .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) :1293-1300

[23] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis [J].

Ferrucci, Silvia ;

Casazza, Giovanni ;

Zussino, Martina ;

Tavecchio, Simona ;

Marzano, Angelo V. ;

Tedeschi, Micol .

JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)

[24] Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis [J].

Beck, Lisa A. ;

Muraro, Antonella ;

Boguniewicz, Mark ;

Chen, Zhen ;

Zahn, Joseph ;

Marco, Ainara Rodriguez .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (01) :135-143

[25] Comparison of Efficacy of Baricitinib and Dupilumab in the Treatment of Chinese Moderate-To-Severe Atopic Dermatitis: A Retrospective Study [J].

Liu, Bo ;

Song, Xiaoting ;

Liao, Shuanglu ;

Luan, Tingting ;

Zhao, Zuotao .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (10) :966-974

[26] Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years [J].

Elaine C. Siegfried ;

Eric L. Simpson ;

Michael J. Cork ;

Peter D. Arkwright ;

Lara Wine Lee ;

Zhen Chen ;

Randy Prescilla ;

Ashish Bansal ;

Noah A. Levit ;

Ainara Rodríguez Marco .

Dermatology and Therapy, 2023, 13 :1987-2000

[27] Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years [J].

Siegfried, Elaine C. ;

Simpson, Eric L. ;

Cork, Michael J. ;

Arkwright, Peter D. ;

Wine Lee, Lara ;

Chen, Zhen ;

Prescilla, Randy ;

Bansal, Ashish ;

Levit, Noah A. ;

Rodriguez Marco, Ainara .

DERMATOLOGY AND THERAPY, 2023, 13 (09) :1987-2000

[28] Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis [J].

Beck, Lisa A. ;

Simpson, Eric L. ;

Ramien, Michele ;

Tang, Mark ;

Joyce, Joel C. ;

Praestgaard, Amy ;

Rossi, Ana B. ;

Clearfield, Drew ;

Zhang, Annie .

BRITISH JOURNAL OF DERMATOLOGY, 2024, 191

[29] Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis [J].

Awosika, Olabola ;

Kim, Lori ;

Mazhar, Momina ;

Rengifo-Pardo, Monica ;

Ehrlich, Alison .

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2018, 11 :41-49

[30] Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab [J].

Silverberg, Jonathan, I ;

Simpson, Eric L. ;

Thyssen, Jacob P. ;

Pink, Andrew E. ;

Weidinger, Stephan ;

Chan, Gary ;

Lazariciu, Irina ;

Clibborn, Claire ;

Guler, Erman .

BRITISH JOURNAL OF DERMATOLOGY, 2023, 188

← 1 2 3 4 5 →